Lung Cancer
3,102
435
572
1,533
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
406 trials with published results (13%)
Research Maturity
1533 completed trials (49% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.1%
282 terminated out of 3102 trials
84.5%
-2.1% vs benchmark
7%
218 trials in Phase 3/4
26%
406 of 1533 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1533 completed trials
Clinical Trials (3103)
Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer
Adaptive Symptom Self-Management Immunotherapy Study
A Study of a Side Effects and Resource Navigation Program for People With Cancer
A COhort Study on Factors Leading to Vulnerability in Adult Patients With Serious Medical cOnditionS: the COSMOS-I Trial
The Development, Safety, and Feasibility of an Artificial Intelligence-Powered Platform (NodeAI) for Real-Time Prediction of Mediastinal Lymph Node Malignancy During Endobronchial Ultrasound Staging for Lung Cancer
Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy
REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE)
Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer
Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry
The Effect of Immersive Virtual Reality and Relaxing Videos on Lung Cancer Patients
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
Collection of Blood From Patients With Cancer
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations
Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China
Effects of Infusion Timing on Treatment Response in Solid Tumors
A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors
IDOV-Immune for Advanced Solid Tumors
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Empathic Communication Skills (ECS) Training